Cancer chemopreventive activity of phenylpropanoids and phytoquinoids from Illicium plants

被引:64
作者
Itoigawa, M
Ito, C
Tokuda, H
Enjo, F
Nishino, H
Furukawa, H
机构
[1] Tokai Gakuen Univ, Tempaku Ku, Nagoya, Aichi 4688514, Japan
[2] Meijo Univ, Fac Pharm, Tempaku Ku, Nagoya, Aichi 4688503, Japan
[3] Kyoto Prefectural Univ Med, Dept Mol Biochem, Kyoto 6020841, Japan
关键词
phenylpropanoids; phytoquinoids; Illicium; cancer chemopreventive activity; anti-tumor promoter; Epstein-Barr virus activation test;
D O I
10.1016/j.canlet.2004.05.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In our joint project involving search of anti-tumor promoters from natural plant sources, six phenylpropanoids and seven phytoquinoids isolated from three Illicium plants (Illiciaceae) were tested for their inhibitory activities against Epstein-Barr virus early antigen (EBV-EA) activation induced by 12-O-tetradecanoyl phorbol-13-acetate in Raji cells. All tested compounds showed inhibitory activity against the EBV-EA activation even at 1 X 10 mol ratio, and the inhibitory activity of their compounds was found to be more than that of beta-carotene. Two pherylpropanoids having prenyl group, 4-allyl-2-methoxy-6-(3methyl-2-butenyl)phenol (3) and 4-allyl-2,6-dimethoxy-3-(3-methyl-2-butenyl)phenoI (4), showed more potent activities as anti-tumor promoters (IC50 224 and 217 mol ratio/TPA, respectively). The presence of a prenyl moiety in the phenylpropanoids plays an important role in anti-tumor promoting activity as xanthone, coumarin and flavonoid previously reported. This investigation indicated that prenylated pherylpropanoids might be valuable as potential cancer chemopreventive agents. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:165 / 169
页数:5
相关论文
共 11 条
  • [1] Anti-tumor-promoting effects of 8-substituted 7-methoxycoumarins on Epstein-Barr virus activation assay
    Ito, C
    Itoigawa, M
    Furukawa, H
    Tokuda, H
    Okuda, Y
    Mukainaka, T
    Okuda, M
    Nishino, H
    [J]. CANCER LETTERS, 1999, 138 (1-2) : 87 - 92
  • [2] Anti-tumor-promoting effects of isoflavonoids on Epstein-Barr virus activation and two-stage mouse skin carcinogenesis
    Ito, C
    Itoigawa, M
    Tan, HTW
    Tokuda, H
    Mou, XY
    Mukainaka, T
    Ishikawa, T
    Nishino, H
    Furukawa, H
    [J]. CANCER LETTERS, 2000, 152 (02) : 187 - 192
  • [3] Anti-tumor-promoting effects of phenylpropanoids on Epstein-Barr virus activation and two-stage mouse skin carcinogenesis
    Ito, C
    Itoigawa, M
    Furukawa, H
    Ichiishi, E
    Mukainaka, T
    Okuda, M
    Ogata, M
    Tokuda, H
    Nishino, H
    [J]. CANCER LETTERS, 1999, 142 (01) : 49 - 54
  • [4] Xanthones as inhibitors of Epstein-Barr virus activation
    Ito, C
    Itoigawa, M
    Furukawa, H
    Rao, KS
    Enjo, F
    Bu, P
    Takayasu, J
    Tokuda, H
    Nishino, H
    [J]. CANCER LETTERS, 1998, 132 (1-2) : 113 - 117
  • [5] ANISATIN, A POTENT GABA ANTAGONIST, ISOLATED FROM ILLICIUM-ANISATUM
    KUDO, Y
    OKA, J
    YAMADA, K
    [J]. NEUROSCIENCE LETTERS, 1981, 25 (01) : 83 - 88
  • [6] Murakami A, 1996, BIOSCI BIOTECH BIOCH, V60, P1, DOI 10.1271/bbb.60.1
  • [7] OGURA M, 1976, LLOYDIA, V39, P255
  • [8] TSUSHIMA M, 1995, BIOL PHARM BULL, V18, P227, DOI 10.1248/bpb.18.227
  • [9] YAKUSHIJIN K, 1984, CHEM PHARM BULL, V32, P11
  • [10] YAKUSHIJIN K, 1983, CHEM PHARM BULL, V31, P2879